Ready to accelerate your cell therapy development? Lipid nanoparticles (LNPs) are rapidly emerging as a versatile and scalable delivery platform for cell ...

In this webinar, we explore key considerations and best practices for scaling AAV production, including selecting a transient transfection cell line and sc...

Unlock advanced approaches to scalable plasmid DNA (pDNA) production in this on-demand webinar, designed for CDMOs and Translational Centers seeking to enh...

Cell and gene therapies are entering a transformative era driven by the need for scalable, cost-effective, and safe gene editing and delivery technologies....

When it comes to cell therapy manufacturing, you’re not just in production. You’re crafting hope for millions awaiting these breakthrough treatments. And e...

Cell therapy starting material varies significantly, presenting challenges in maintaining a standardized and reproducible manufacturing process. With the r...

Looking to streamline your CAR T cell process? Discover how lipid nanoparticles (LNP) deliver base editing tools to generate fratricide-resistant CD45-edit...

Delivering nucleic acids using lipid nanoparticles (LNP) to target cells has tremendous potential to enable new cell and gene therapies. In this webinar, w...

Register for this webinar to: learn how to improve the quality of our results, view the AKTA oligosynt™ synthesizer and find out how it can maximize your o...

Register for this webinar to: learn about the oligo therapeutic market, gain insight on the challenges you may face when bringing your process in house and...

Register for this webinar to: learn about the complete oligo workflow from Cytiva, find out what reagents are available and how these are optimized for use...

CAR T therapies are gaining increased attention due to their demonstrated potential in patient outcomes. For a successful commercialization of these therap...

Reduce operator-derived errors with the help of Sefia™ platform. Keep an eye on how everything is going: the system’s functionally closed design and automa...

According to data from our 2023 Global Biopharma Resilience Index, 55% of pharma leaders are happy with the speed of drug approvals — meaning 45% feel ther...

Learn all about Fast Trak™ services from Cytiva from our very own Fast Trak™ Global Technical Leader, Sabrina Carmichael. In this video, you’ll get an over...

The separation of adeno-associated virus (AAV) with high yield and purity is an increasingly important challenge. Mechanistic modeling is the tool of choic...

As cell therapy rapidly progresses, tumor infiltrating lymphocyte (TIL) therapies are playing a significant role in shaping the field. What milestones ena...

In this webinar, we’ll discuss our journey in becoming the first GMP-certified cell and gene therapy manufacturing facility in Thailand. During the journey...

Learn more about the latest addition to our family of single use chromatography systems and how this will enable you to better purify small volumes in a GM...

In the early clinical development stage of autologous cell therapy manufacture, labor costs often dominate the overall cost of goods sold. However, as manu...